[Hiring] Director, Strategic Pricing, Contracts @Revolution Medicines

Role Description

Revolution Medicines is seeking a Director, US Strategic Pricing, to develop and lead brand and portfolio strategic net pricing recommendations to include:

• Pricing and contract research
• Advanced analytics
• Contract design recommendations
• Gross-to-net forecasting to inform net price strategies and recommendations

The Director will oversee provider contracting strategy, including engagements with:

• Group Purchasing Organizations (GPOs)
• Integrated Delivery Networks (IDNs)
• Integrated health systems
• Government customers

Responsibilities include:

• Evaluating contract structures
• Assessing provider economics
• Ensuring contracting approaches align with site-of-care, reimbursement, and policy considerations
• Developing and delivering executive-level pricing and contracting materials for Quarterly Business Reviews (QBRs)

The Director will report to the Senior Director, US Strategic Pricing and will serve in a critical function to shape net pricing recommendations and strategies as the company grows as a commercial organization. This role can be based in Redwood City, CA or can be remotely based with up to 15% travel.

Qualifications

• Bachelor’s degree
• 10+ years of pharmaceutical market access experience
• 4+ years of Oncology product experience
• 6+ years pricing and payer/provider contracting experience
• Extensive experience in customer segment contract strategy
• Strong understanding of IRA policy guidelines and CMS price demonstrations
• Experience with day-to-day management of vendor partners
• Strong knowledge of trends, issues, and policies influencing drug pricing and oncology market
• Ability to communicate effectively, both orally and in writing
• Ability to deliver strategy and price recommendations to various audience types
• Embrace cross-functional collaboration with internal and external customers
• Ability to resolve conflicts and align multiple departments

Requirements

• Experience with oral oncology therapies and targeted treatments for RAS-mutated cancers (preferred)
• Advanced degree (MBA, MPH, or similar) (preferred)

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities

Company Description

Revolution Medicines is a global, commercial-stage oncology company dedicated to discovering, developing, and delivering innovative medicines for patients with RAS-addicted cancers. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients worldwide.